NCT05914844View on ClinicalTrials.gov

Investigation Of Receptivity Markers For Endometrial Cancer Treatment Development

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

November 19, 2021

Primary Completion Date

August 17, 2022

Study Completion Date

February 1, 2023

Conditions
Endometrial Cancer Stage
Trial Locations (1)

45030

Manisa Celal Bayar University, Yunusemre

All Listed Sponsors
lead

Celal Bayar University

OTHER

NCT05914844 - Investigation Of Receptivity Markers For Endometrial Cancer Treatment Development | Biotech Hunter | Biotech Hunter